News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biotech Receptos Files for a $86 Million IPO



4/5/2013 7:44:19 AM

Receptos, a biotech with a Phase 3 drug candidate for relapsing multiple sclerosis, filed on Thursday with the SEC to raise up to $86 million in an initial public offering. The San Diego, CA-based company, which was founded in 2008 and has yet to generate any revenue from drug sales, plans to list on the NASDAQ under the symbol RCPT.

Read at Nasdaq
Read at News Release


comments powered by Disqus
Receptos
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES